11
Participants
Start Date
July 31, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Lacosamide
4-Week Titration Period: start dose Lacosamide (LCM) is 100 mg/day - up-titration of 100 mg/week LCM 8-Week Maintenance Period: dose can change first 4 weeks with 100 mg/week, must remain between 300 mg/day and 600 mg/day. Dose must remain stable last 4 weeks.
Levetiracetam
Levetiracetam (LEV) is taken at a stable dose 30 days before study entry and is ≥ 1000 mg/day at the first visit. The LEV dose may not be changed at any time.
11, Innsbruck
12, Salzburg
2, Bielefeld
1, Bonn
5, Erlangen
22, Alcorcón
20, Santiago de Compostela
Lead Sponsor
UCB Pharma
INDUSTRY